During the past decade, PsychCare Consultants Research conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 18 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PsychCare Consultants Research" #1 sponsor was "Sunovion" with 8 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 5 trials sponsored, "Titan Pharmaceuticals" with 4 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PsychCare Consultants Research" #1 collaborator was "Michael J. Fox Foundation for Parkinson's Research" with 1 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator, "Otsuka America Pharmaceutical" with 1 trials as a collaborator and "University of Michigan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "PsychCare Consultants Research" are "Schizophrenia" (10 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Bipolar I Disorder" (2 trials), "Depressive Disorder, Major" (2 trials) and "Major Depressive Disorder" (2 trials). Many other conditions were trialed in "PsychCare Consultants Research" in a lesser frequency.

Most popular intervention types in "PsychCare Consultants Research" are "Drug" (33 trials), "Other" (4 trials), "Device" (2 trials), "Combination Product" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Lurasidone" (4 trials), "Probuphine (buprenorphine implant)" (3 trials), "AVP-786" (2 trials) and "Eslicarbazepine acetate" (2 trials). Other intervention names were less common.

The vast majority of trials in "PsychCare Consultants Research" are 38 trials for "All" genders.

Currently, there are NaN active trials in "PsychCare Consultants Research". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 24 completed trials in PsychCare Consultants Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in PsychCare Consultants Research, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".